A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy
Sponsor: Paion UK Ltd.
Listed as NCT02296892, this PHASE3 trial focuses on Bronchoscopy and remains completed. Sponsored by Paion UK Ltd., it has been updated 12 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Dec 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 7 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Apr 2019 — Apr 2020 [monthly]
Completed PHASE3
-
Sep 2018 — Apr 2019 [monthly]
Completed PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Completed PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Paion UK Ltd.
- Premier Research
For direct contact, visit the study record on ClinicalTrials.gov .